As returns on market increase, Smith returns are expected to increase less than the market. However during bear market, the loss on holding Smith will be expected to be smaller as well.
John Buchanan Non-Executive Independent Chairman of the Board, Ph.D
Olivier Bohuon CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance Committee
Mark Augusti President - Clinical Therapies/Biologics
The median price of Smith for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 58.34 with a coefficient of variation of 2.03. The daily time series for the period is distributed with a sample standard deviation of 1.18, arithmetic mean of 58.07, and mean deviation of 0.93. The Stock did not receive any noticable media coverage during the period.
Smith Nephew plc [SNN] is traded on New York Stock Exchange in USA. It is located in London, WCN LA and employs 10,000 people. The company currently falls under 'Mid-Cap' category with total capitalization of 9.94 B. Smith Nephew plc runs under Healthcare sector within Medical Appliances and Equipment industry. This company has 180.72 M outstanding shares of which 862.31 K shares are at this time shorted by investors with about 10.2 days to cover shorted positions.
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
0.32%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
